Intra-Individual Variability of the Metabolic Effect of a Novel Rapid-Acting Insulin (VIAject™) in Comparison to Regular Human Insulin

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Diabetes Science and Technology

• Publication date

  2008-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/193229680800200406PMID 19885231PMCID PMC2769777
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Comparison of the time-action profiles of U40- and U100-regular human insulin and the rapid-acting insulin analogue B28 Asp.

  2009cited by this paper
• A novel insulin formulation with a more rapid onset of action

  2008cited by this paper
• Variability of Insulin Action : Does It Matter ?

  2008cited by this paper
• Variability of Insulin Action: Does It Matter?

  2008cited by this paper
• Delivery compositions rapid acting drug

  2005cited by this paper
• Lower within-subject variability of insulin detemir in comparison to NPH insulin and insulin glargine in people with type 1 diabetes.

  2004cited by this paper

• Interindividual Variability in the Pharmacodynamic and Pharmacokinetic Characteristics of Recombinant Human Insulin and Insulin Aspart.

  2021cites this paper
• Contrôle de la glycémie post-prandiale : apport des nouvelles formulations d’insuline ultra-rapides

  2020cites this paper
• Current Applications of Pharmaceutical Biotechnology

  2020cites this paper
• Hormones, Blood Products, and Therapeutic Enzymes.

  2019cites this paper
• 9 Insulin Therapy and Hypoglycemia-Present and Future

  2017cites this paper
• NOVEL APPROACHES IN INSULIN DRUG DELIVERY

  2017cites this paper
• [New insulin types in type 1 diabetes mellitus].

  2015cites this paper
• Smart Bolus Estimation Taking into Account the Amount of Insulin on Board

  2015cites this paper
• New insulin developments

  2015cites this paper
• New Insulins and New Aspects in Insulin Delivery.

  2015cites this paper
• Clinical Use of New Insulins and New Insulin Delivery Systems

  2015cites this paper
• New insulin types in type 1 diabetes mellitus

  2015cites this paper
• Nuevas insulinas en la diabetes tipo 1

  2015cites this paper
• Recent Advances in Insulin Therapy for Diabetes

  2014influential citation
• Design of ultra-stable insulin analogues for the developing world

  2013cites this paper
• Variability of glucose‐lowering effect as a limiting factor in optimizing basal insulin therapy: a review

  2013cites this paper
• Insulin therapies: Current and future trends at dawn.

  2013cites this paper
• Insulin Therapy for Diabetes

  2013cites this paper
• New Insulins and Insulin Therapy

  2013cites this paper
• New insulins and insulin therapy

  2012cites this paper
• Design of Non-Standard Insulin Analogs for the Treatment of Diabetes Mellitus

  2012cites this paper
• The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences

  2012cites this paper
• Ultra-Rapid Absorption of Recombinant Human Insulin Induced by Zinc Chelation and Surface Charge Masking

  2012cites this paper
• Insulins: past, present, and future.

  2012cites this paper
• Insulin therapy and hypoglycemia.

  2012cites this paper
• A Review of a Family of Ultra-Rapid-Acting Insulins: Formulation Development

  2012cites this paper
• Pharmacokinetics and Postprandial Glycemic Excursions following Insulin Lispro Delivered by Intradermal Microneedle or Subcutaneous Infusion

  2012cites this paper
• Advanced Technologies and Treatments for Diabetes

  2012cites this paper
• Adding glucagon-like peptide-1 receptor agonists to insulin the rapy for patients with type 2 diabetes mellitus: why and how?

  2012cites this paper
• Co nowego w terapii cukrzycy typu 1

  2012cites this paper
• Ultrafast-Acting Insulins: State of the Art

  2012cites this paper
• Insulin analogs for the treatment of diabetes mellitus: therapeutic applications of protein engineering

  2011cites this paper
• Reduction of Postprandial Glycemic Excursions in Patients with Type 1 Diabetes: A Novel Human Insulin Formulation versus a Rapid-Acting Insulin Analog and Regular Human Insulin

  2011cites this paper
• On the use of hard/soft specifications to deal with intra-patient variability in postprandial glucose control in type 1 diabetes1

  2011cites this paper
• Insulin Therapy and Hypoglycemia - Present and Future

  2011cites this paper
• Diabetes - Damages and Treatments

  2011cites this paper
• New insulins and insulin therapy.

  2011cites this paper
• Insulin Pumps in Young Children

  2010cites this paper